Progression of kidney dysfunction in the community-dwelling elderly.

[1]  P. Houillier,et al.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. , 2005, Journal of the American Society of Nephrology : JASN.

[2]  Adrian G Barnett,et al.  Regression to the mean: what it is and how to deal with it. , 2004, International journal of epidemiology.

[3]  O. Djurdjev,et al.  The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Amit X Garg,et al.  Classifying kidney problems: can we avoid framing risks as diseases? , 2004, BMJ : British Medical Journal.

[5]  Philip McFarlane,et al.  Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  P. Stevens,et al.  Unreferred chronic kidney disease: a longitudinal study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  C. Gullion,et al.  Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.

[8]  D. Siscovick,et al.  Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. , 2004, The American journal of geriatric cardiology.

[9]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[10]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[11]  C. Albert,et al.  Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. , 2003, The American journal of cardiology.

[12]  David W Dunstan,et al.  Prevalence of kidney damage in Australian adults: The AusDiab kidney study. , 2003, Journal of the American Society of Nephrology : JASN.

[13]  R. Kronmal,et al.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.

[14]  Jackson T. Wright,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial , 2003 .

[15]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[16]  H. Clark,et al.  Serum creatinine is an inadequate screening test for renal failure in elderly patients. , 2003, Archives of internal medicine.

[17]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[19]  Nancy Fink,et al.  The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.

[20]  F. Kronenberg,et al.  Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. , 2002, Journal of the American Society of Nephrology : JASN.

[21]  H. Trivedi,et al.  Slowing the progression of chronic renal failure: economic benefits and patients' perspectives. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  E. Lewis,et al.  Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes , 2002 .

[24]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .

[25]  J G Ray,et al.  Estimation of creatinine clearance in elderly persons in long-term care facilities. , 2001, The American journal of medicine.

[26]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[27]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[28]  B. Manns,et al.  The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. , 2001, Clinical and investigative medicine. Medecine clinique et experimentale.

[29]  H. Parving,et al.  Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. , 2001, Kidney international.

[30]  O. Djurdjev,et al.  Screening for renal disease using serum creatinine: who are we missing? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  D. Bates,et al.  Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  D. Levy,et al.  Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. , 2000, The American journal of medicine.

[33]  G. Burke,et al.  Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. , 2000, Kidney international.

[34]  Giuseppe Remuzzi,et al.  Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria , 1999, The Lancet.

[35]  L. Ferrucci,et al.  Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. , 1998, Archives of internal medicine.

[36]  S. Leurgans,et al.  Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. , 1996, Kidney international.

[37]  Gregory E. Simon,et al.  A Chronic Disease Score with Empirically Derived Weights , 1995, Medical care.

[38]  P. Diggle.  Analysis of Longitudinal Data , 1995 .

[39]  D. Altman,et al.  Statistic Notes: Regression towards the mean , 1994, BMJ.

[40]  D G Altman,et al.  Correlation, regression, and repeated data. , 1994, BMJ.

[41]  Douglas G. Altman,et al.  Statistics Notes: Correlation, regression, and repeated data , 1994 .

[42]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[43]  C. Kjellstrand,et al.  Canadian Organ Replacement Register. , 1994, Le Journal CANNT = CANNT journal : the journal of the Canadian Association of Nephrology Nurses and Technicians.

[44]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[45]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[46]  H. Mulec,et al.  Renal protective effect of enalapril in diabetic nephropathy. , 1992 .

[47]  A. Levey,et al.  Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. , 1991, Journal of the American Society of Nephrology : JASN.

[48]  H. Parving,et al.  Prognosis in diabetic nephropathy. , 1989, BMJ.

[49]  N W Shock,et al.  Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.

[50]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.